Page 149 - Syndipharma

Sina Darou Laboratories Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Founded: 1342(1963)

HQ Office: Tehran-Iran
Plant Location: Tehran-Iran

Capital: 400/000/000/000 Rials

Major Shareholder: Kharazmi Investment Company,
Employees: 485
Company Profile:
Sina Darou Laboratories Company (EX-“Dopar Laboratories Company”) was set up in 1962 in Iran under license of a
French Company. During more than fifty-year activity in the pharmaceutical industry, the company has been employ-
ing qualified and skilled pharmacists, chemists, and technicians. In addition to modern machinery installation, equip-
ping the laboratories with new analytical instruments and utilizing facilities along with decades of gaining scientific
knowledge has brought the company up to date in all its sections, which conforms to the latest standards.
Sina Darou Laboratories Company produces more than 100 various formulations. The goal of the company is achiev-
ing the highest quality. In this regards, the company implements the total quality management in all of its activities.
All of the documents in the related departments are based on Quality Management System (ISO 9001 2015), which
are approved by quality assurance in strict conformity to GMP conditions of WHO with regular inspections by the re-
gional health authorities. Sina Darou Laboratories Company manufactures a wide range of pharmaceutical products
such as sterile ones (including ampoules, eye & ear drops, eye ointments, eye irrigation solutions and single dose
sterile eye drops), lotions and topical sprays, gels, ointments, creams, nasal drops and metered dose Inhalers and
also plastic containers for pharmaceutical products. For the first time in Iran, the single-dose drop production line
was launched in Sina Darou Company in 2015.
The company implements research projects collaborating with Iranian medical universities and European pharma-
ceutical manufacturers to improve knowledge and develop new products.
Since 2015, in order to upgrade knowledge and synchronize global technologies, Sina Darou has started a new proj-
ect including the production lines, the administrative buildings and the warehouses. And the production of eye and
nasal drops with BFS technology is on the agenda.
Sina Darou is operated by more than 480 skilled personnel and in addition to supplying domestic need, it has been
exporting its products to neighboring countries and it will achieve a great share of pharmaceutical export among the
rivals.
Production Lines:
Ophthalmic/Otic/Nasal Drops, Ophthalmic Ointments, Nasal and Topical Sprays, Metered Dose Inhalers, Ampoules,
Topical & Vaginal Ointments and Creams
Certificates:
ISO 9001 : 2015

Target Countries for Exports:
Iraq, Afghanistan, Azerbaijan, Syria, Tajikistan, Ukraine, Belorussia, Russia, Somalia, Algeria, Uzbekistan

148